National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

This is VAERS ID 1304083

Government Disclaimer on use of this data



Case Details

VAERS ID: 1304083 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-10
Onset:2021-04-20
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-05-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2246 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Electroencephalogram, Oxygen saturation, SARS-CoV-2 test, Scan brain, Status epilepticus
SMQs:, Systemic lupus erythematosus (broad), Convulsions (narrow), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-23
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: OMEPRAZOL; CALCIUM CARBONATE AND VITAMIN D; ACETYLSALICYLIC ACID; AMLODIPINE; SODIUM VALPROATE; PROLIA; TRAZODONE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cognitive impairment (Mild); Disorientation; Dysarthria; Facial droop (Right hemiparesis from childhood due to Infantile Paralysis); Hospitalization (due to dysarthria and disorientation, with a diagnosis of isovolemic hypotonic hyponatremia); Hypertension arterial; Hyponatremia; Inappropriate ADH secretion (uncertain etiology); Pain loin; Paraphasia; UTI (due to multisensitive E. Coli.); Ventricular bigeminy
Allergies:
Diagnostic Lab Data: Test Date: 20210420; Test Name: EEG; Result Unstructured Data: Test Result:Focal status epilepticus; Test Date: 20210420; Test Name: SatO2; Test Result: 87 %; Test Date: 20210420; Test Name: SARS-CoV-2 PCR test; Test Result: Positive ; Test Date: 20210420; Test Name: Scan brain; Result Unstructured Data: Test Result:Residual areas of left frontoparietal encephalomal; Comments: Residual areas of left frontoparietal encephalomalacia. No signs of acute intracranial pathology
CDC Split Type: ESPFIZER INC2021496694

Write-up: Status epilepticus; SARS-COV2 PCR: Positive; This is a spontaneous report received from a contactable physician downloaded from the regulatory authority. The regulatory authority report number is ES-AEMPS-846623. A 79-year-old female patient received the first dose of BNT162B2 (COMIRNATY, lot: EW2246), intramuscularly on 10Apr2021 at 0.3 mL single for COVID-19 immunisation. Medical history included arterial hypertension, pain loin, ventricular bigeminy, facial droop (right hemiparesis from childhood due to infantile paralysis), and mild cognitive impairment. She was admitted from 01Apr2021 to 09Apr2021 due to dysarthria and disorientation, with a diagnosis of isovolemic hypotonic hyponatremia, SIAD (syndrome of inappropriate antidiuretic hormone secretion) (uncertain etiology), and UTI (urinary tract infection) due to multisensitive E. Coli. Concomitant medications included omeprazole, calcium carbonate/colecalciferol (CALCIUM CARBONATE AND VITAMIN D), acetylsalicylic acid 100 mg, amlodipine, sodium valproate, denosumab (PROLIA), and trazodone. On 16Apr2021 she went to the Emergency Service of a hospital due to paraphasia and disorientation, starting treatment with valproic and was discharged. On 20Apr2021, she was admitted due to a non-convulsive status, with progressive onset in recent weeks despite treatment with valproic acid ((poor compliance). No evidence of epilepsy until Apr2021, but there were episodes of similar characteristics on admission in 2020 Therefore, it does not seem like status epilepticus in the context of any acute trigger, but rather a serious epileptic decompensation within an infectious occurrence such as covid19. Previous etiological study without significant alterations, although the patient suffered from infantile cerebral palsy and had mild-moderate cognitive impairment. Diagnostics: Complex focal epileptic status, in a patient with residual brain injury that might be the etiology of the seizure, the injury was old and had decompensated 10 days after vaccination. Severe bilateral pneumonia from COVID19. Lab data on 20Apr2021 included: CT (computed tomography): No signs of acute intracranial pathology. Residual areas of left frontoparietal encephalomalacia; SARS-COV2 PCR: Positive; EEG (electroencephalogram) on admission: Focal status epilepticus; The main novelty was a respiratory worsening, with work of breathing and SatO2(Oxygen saturation) 87% with GN at 6lp. At the respiratory level: Bilateral pneumonia due to severe covid19, requiring oxygen therapy with GN at 5 bpm. COURSE: No improvement despite pharmacological adjustment after 24h. The patient died on 23Apr2021. No autopsy was done. Assessment of causality (SEFV): The patient had severe bilateral Covid-19 pneumonia. Status epilepsy had been described in positive CoVID-19 patients, so there was an alternative causal explanation to the vaccine that could explain the condition. Outcome of event SARS-COV2 PCR: Positive was unknown. No follow-up attempts are possible. No further information expected.; Reported Cause(s) of Death: Status epilepticus


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1304083


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166